naltrexone has been researched along with s,n,n'-tripropylthiocarbamate in 123 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (4.88) | 18.7374 |
1990's | 17 (13.82) | 18.2507 |
2000's | 29 (23.58) | 29.6817 |
2010's | 58 (47.15) | 24.3611 |
2020's | 13 (10.57) | 2.80 |
Authors | Studies |
---|---|
Kirkham, TC | 1 |
Di Chiara, G; Imperato, A | 1 |
Van Ree, JM | 1 |
Corrigall, WA; D'Onofrio, RM; Lei, H; Linseman, MA | 1 |
Carr, KD; Uysal, S | 1 |
Cooper, SJ | 1 |
Carr, KD | 2 |
Heidbreder, C; Shippenberg, TS | 1 |
Carr, KD; Papadouka, V; Wolinsky, TD | 1 |
Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T | 1 |
Carr, KD; Papadouka, V | 1 |
Babovic-Vuksanovic, D; de Vries, TJ; Elmer, G; Shippenberg, TS | 1 |
Heidbreder, C; LeFevour, A; Shippenberg, TS | 1 |
Amendola, CA; Fishkin, MD; Hubbell, CL; Reid, LD; Tsai, J | 1 |
Endoh, T; Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M | 1 |
Boedeker, KL; Cramer, CM; Gardell, LR; Harris, JR; Hubbell, CL; Reid, LD | 1 |
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD | 1 |
Anton, RF | 1 |
Brodkin, ES; Carlezon, WA; Duman, RS; Hiroi, N; Lane-Ladd, SB; Nestler, EJ; Neve, RL; Olson, VG; Thome, J | 1 |
Kishimoto, Y; Misawa, M; Nagase, H; Suzuki, T; Takeda, F | 1 |
Cuison, ER; Groseclose, CH; Kelley, BM; Middaugh, LD | 2 |
Williams, KL; Woods, JH | 1 |
Bandy, AL; Lee, AM; Middaugh, LD | 1 |
Matsumiya, T; Nagase, H; Narita, M; Suzuki, T; Takeda, H; Tsuji, M | 1 |
Ball, SA; Carroll, KM; Eagan, DA; Frankforter, TL; Nich, C; O'Connor, PG; Rounsaville, BJ; Shi, J; Triffleman, EG | 1 |
Gray, RW; Yeomans, MR | 1 |
Chavkin, C; Marton-Popovici, M; McLaughlin, JP | 1 |
Carlezon, WA; Marcus, JF; Portoghese, PS; Todtenkopf, MS | 1 |
de la Torre, R; Kieffer, BL; Maldonado, R; Mendizabal, V; Ortuño, J; Robledo, P | 1 |
Ise, Y; Kishimoto, Y; Misawa, K; Narita, M; Suzuki, T; Yajima, Y | 1 |
Anggadiredja, K; Hiranita, T; Sakimura, K; Yamamoto, T | 1 |
Burns, LH; Olmstead, MC | 1 |
Burns, LH; Leri, F | 1 |
Miller, MC | 1 |
Riters, LV; Schroeder, MB | 1 |
Jasmin, L; Narasaiah, M; Tien, D | 1 |
Boettiger, CA; D'Esposito, M; Fields, HL; Mitchell, JM; Tavares, VC | 1 |
Braida, D; Gori, E; Guerini-Rocco, C; Limonta, V; Pegorini, S; Sala, M; Zani, A | 1 |
Aicardi, G; Burattini, C; Burbassi, S; Cervo, L | 1 |
Krishnan-Sarin, S; Krystal, JH; O'Malley, SS; Pittman, B; Shi, J | 1 |
Billington, CJ; Chimukangara, M; Grace, MK; Levine, AS; Naleid, AM | 1 |
Holtzman, SG; Michaels, CC | 1 |
Blendy, J; Jepson, C; Lerman, C; Patterson, F; Perkins, K; Ray, R; Rukstalis, M; Strasser, AA; Wileyto, P | 1 |
Hutchison, KE; Ray, LA | 1 |
Braida, D; Capurro, V; Fadda, P; Fratta, W; Gori, E; Limonta, V; Mascia, P; Parolaro, D; Rubino, T; Sala, M; Zani, A | 1 |
Stitzer, ML; Vandrey, R | 1 |
Chefer, VI; Shippenberg, TS | 1 |
Franck, J; Häggkvist, J; Lindholm, S | 1 |
Kato, H | 1 |
Dean, RL; Deaver, DR; Kriksciukaite, K; O'Neill, KS; Ostrovsky-Day, I; Todtenkopf, MS; Turncliff, RZ | 1 |
Gieryk, A; Kubik, J; Przewlocki, R; Solecki, W; Ziolkowska, B | 1 |
Berrendero, F; Maldonado, R; Martín-García, E; Robledo, P; Trigo, JM | 1 |
Carey, AN; Gomes, SM; McLaughlin, JP; Sperling, RE; Sypek, EI | 1 |
Chavkin, C; Li, S; Schindler, AG | 1 |
Brown, ML; Kellar, KJ; Levin, ED; Li, TK; Lumeng, L; McDowell, BE; Paige, MA; Petro, A; Rezvani, AH; Rose, JE; Slade, S; Wells, C; Xiao, Y | 1 |
Berthoud, HR; Phifer, CB; Pistell, PJ; Shin, AC | 1 |
Chung, NN; Gibula-Bruzda, E; Izdebski, J; Kotlinska, JH; Kunce, D; Pachuta, A; Schiller, PW; Witkowska, E | 1 |
Balleine, BW; Cely, IC; Maidment, NT; Wassum, KM | 1 |
Beaver, J; Bullmore, ET; Bush, MA; Gunn, RN; Hill, S; Howard, J; Long, C; Makwana, A; Matthews, PM; Miller, SR; Nathan, PJ; Newbould, RD; Passchier, J; Rabiner, EA; Reiley, R; Searle, G | 1 |
Carlezon, WA; Chartoff, EH; Cohen, BM; Damez-Werno, D; Potter, DN | 1 |
Fish, EW; Heilig, M; Krouse, MC; Malanga, CJ; Robinson, JE; Thorsell, A | 1 |
Busch, EL; Elman, I; Langleben, DD; O'Brien, CP | 1 |
Dickson, SL; Hansson, C; Shirazi, RH; Skibicka, KP | 1 |
Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA | 1 |
Balleine, BW; Laurent, V; Leung, B; Maidment, N | 1 |
Friedman, TC; Hamid, A; Kieffer, B; Lutfy, K; Marquez, P; Nguyen, AT | 1 |
Carlsson, A; Feltmann, K; Franck, J; Fredriksson, I; Holst, S; Schilström, B; Steensland, P | 1 |
Chavkin, C; Chavkin, NW; Gustin, RM; Hagan, CE; Lemos, JC; Messinger, DI; Neumaier, JF; Schattauer, SS; Schindler, AG; Shankar, H; Smith, JS | 1 |
Bailey, CP; Cordery, SF; Delgado-Charro, MB; Guy, RH; Husbands, SM; Ridzwan, IE; Taverner, A | 1 |
Arduino, C; Benedetti, F; Blanchard, C; Thoen, W; Vighetti, S | 1 |
Ise, Y; Katayama, S; Mori, T; Nagase, H; Suzuki, T | 1 |
Chelnokova, O; Eikemo, M; Laeng, B; Leknes, S; Løseth, G; Maurud, H; Riegels, J; Willoch, F | 1 |
Brouwer, S; Cowen, PJ; Harmer, CJ; McCabe, C; McCutcheon, R; Murray, E | 1 |
Augier, E; Dulman, RS; Flanigan, M; Heilig, M; Kejun, C; Pincus, A; Rice, KC; Schank, JR; Tapocik, JD | 1 |
Gao, MJ; Kao, JH; Law, PY; Loh, HH; Tao, PL; Yang, PP | 1 |
Bullmore, ET; Felici, A; Henderson, G; Kelly, E; Maltby, K; Mundell, SJ; Nathan, PJ; Roth, AL; Sava, A | 1 |
Ise, Y; Itoh, T; Komiya, S; Masukawa, D; Mizuo, K; Mori, T; Saeki, T; Shibasaki, M; Suzuki, T; Yoshizawa, K | 1 |
Bialy, M; Boguszewski, PM; Nikolaev, E; Nikolaev-Diak, A; Socha, A; Strefnel, M | 1 |
Bilbao, A; Heilig, M; Malanga, CJ; Robinson, JE; Sommer, WH; Spanagel, R; Thorsell, A | 1 |
Berrettini, W | 2 |
Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ | 1 |
Bachtell, R; Hutchinson, MR; Maier, SF; Rice, KC; Wang, X; Watkins, LR | 1 |
Willyard, C | 1 |
Adler, N; Dallman, M; Daubenmier, J; Epel, ES; Gearhardt, AN; Hecht, FM; Kiernan, M; Laraia, B; Lustig, RH; Mason, AE; Puterman, E | 1 |
Abbott, S; Boyapati, V; Deakin, JF; Elliott, R; Erritzoe, D; Ersche, KD; Faluyi, Y; Faravelli, L; Fernandez-Egea, E; Flechais, RS; Kalk, NJ; Kuchibatla, SS; Lingford-Hughes, AR; McGonigle, J; Metastasio, A; Mick, I; Murphy, A; Nestor, L; Nutt, DJ; Orban, C; Passetti, F; Paterson, LM; Rabiner, EA; Reed, LJ; Robbins, TW; Smith, DG; Suckling, J; Tait, R; Taylor, EM; Waldman, AD | 1 |
Eans, SO; Ganno, ML; Hunkele, A; Le Rouzic, V; Majumdar, S; Marrone, GF; McLaughlin, JP; Pasternak, GW; Subrath, JJ; Váradi, A | 1 |
de Carvalho, CR; Takahashi, RN | 1 |
Beck-Schimmer, B; Kajdi, ME; Müller, D; Quednow, BB; Tobler, PN; Weber, SC | 1 |
Mann, K; Roos, CR; Witkiewitz, K | 1 |
Chelnokova, O; Eikemo, M; Laeng, B; Leknes, S; Løseth, G; Willoch, F | 1 |
Bullmore, ET; Deakin, B; Elliott, R; Ersche, KD; Flechais, R; Lingford-Hughes, A; McGonigle, J; Murphy, A; Nestor, LJ; Nutt, DJ; Orban, C; Paterson, LM; Rabiner, I; Reed, L; Robbins, TW; Sahakian, B; Smith, D; Suckling, J; Tait, R; Taylor, E | 1 |
Factor, JA; Panlilio, LV; Schindler, CW; Secci, ME | 1 |
Bolstridge, M; Boyce, M; Breuning Sluth, L; Flechais, RSA; Lingford-Hughes, A; McGonigle, J; Meulien, D; Mick, I; Newbould, RD; Nutt, D; Quelch, DR; Rabiner, E; Ramos, AC; Steiniger-Brach, B; van den Berg, F; von der Goltz, C; Wall, MB; Østergaard Nilausen, D | 1 |
Biele, G; Eikemo, M; Leknes, S; Thomsen, L; Willoch, F | 1 |
Gajbhiye, SV; Petare, A; Potey, AV; Salve, B; Tripathi, RK | 1 |
Anton, RF; Book, SW; Latham, PK; Myrick, H; Randall, PK; Schacht, JP; Voronin, KE | 1 |
Henderson-Redmond, AN; Lowe, TE; Morgan, DJ; Tian, XB | 1 |
Buisman-Pijlman, FTA; Hutchinson, MR; Jacobsen, JHW; Mustafa, S; Rice, KC | 1 |
Bradberry, CW; Panlilio, LV; Schindler, CW; Secci, ME | 1 |
George, O; Kallupi, M; Martin-Fardon, R; Matzeu, A; Schweitzer, P | 1 |
Bouril, A; Elman, I; Fairchild, VP; Gur, RC; Langleben, DD; Lowen, SB; Shi, Z; Wang, AL | 1 |
Heinz, A; Hoffmann, S; Leménager, T; Mann, K; Nakovics, H; Roos, CR; Witkiewitz, K | 1 |
Daniels, S; Flynn, A; Horman, T; Hudson, R; Leri, F; Levy, A; Zhou, Y | 1 |
Boettiger, CA; Da Cunha, C; Esaki, JY; Fiorenza, AM; Gomez-A, A; Robinson, DL; Shnitko, TA; Sullivan, KM; Vemuru, SR | 1 |
Jastrzebska, K; Przewlocki, R; Rodriguez Parkitna, J; Sikora, M; Skupio, U | 1 |
Eikemo, M; Leknes, S; Løseth, GE | 1 |
Andreescu, C; Hazlett, LI; Inagaki, TK | 1 |
Kranzler, HR; Mann, K; Roos, CR; Witkiewitz, K | 1 |
Brunton, C; Carroll, RM; Ewan, EE; Grace, MK; Hahn, TW; Head, MA; Jewett, DC; Klockars, A; Kwilasz, AJ; Levine, AS; Olszewski, PK; Smith, TR; Tham, RL; Wiebelhaus, JM | 1 |
MacDonald, G; Tchalova, K | 1 |
Chalhoub, RM; Kalivas, PW | 1 |
Eisenegger, C; Götzendorfer, SJ; Graf, I; Korb, S; Massaccesi, C; Sezen, P; Silani, G; Willeit, M | 1 |
Bäckström, P; Kiianmaa, K; Oinio, V; Piepponen, P; Raasmaja, A; Sundström, M; Uhari-Väänänen, J | 1 |
Bold, KW; Corbin, WR; DeMartini, KS; Fucito, LM; Kranzler, HR; Leeman, RF; Mann, K; O'Malley, SS; Roos, CR; Witkiewitz, K | 1 |
Kahnt, T; Quednow, BB; Soutschek, A; Tobler, PN; Weber, SC | 1 |
Kranzler, HR; Mann, K; Nakovics, H; Roos, CR; Votaw, VR; Witkiewitz, K | 1 |
Castillo, F; Comer, SD; Jones, JD; Kranzler, HR; Manubay, J; Martinez, S; Mogali, S; Mumtaz, M; Perez, F; Pramanik, S; Vadhan, NP | 1 |
Bower, M; de Wit, H; Hoots, JK; Nunez, C; Schepers, ST; Wardle, MC | 1 |
Antonijoan, RM; Cardona, G; Ferreri, L; Mas-Herrero, E; Pla-Juncà, F; Riba, J; Rodriguez-Fornells, A; Valle, M; Zatorre, RJ | 1 |
Byrd, ND; Gowin, JL; Kirk-Provencher, KT; Penner, AE; Ramchandani, VA; Rosenblatt, SL; Sloan, ME; Stangl, BL; Swan, JE | 1 |
10 review(s) available for naltrexone and s,n,n'-tripropylthiocarbamate
Article | Year |
---|---|
Minireview. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior.
Topics: Animals; Benzodiazepines; Corpus Striatum; Drinking Behavior; Enkephalins; Feeding Behavior; Food Deprivation; Humans; Hyperphagia; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Reward; Thirst | 1983 |
The physiology of opiate hedonic effects and the role of opioids in motivated behavior.
Topics: Animals; Conditioning, Operant; Electric Stimulation; Electroshock; Emotions; Endorphins; Feeding Behavior; Humans; Hypothalamus; Medial Forebrain Bundle; Morphine; Motivation; Naloxone; Naltrexone; Narcotics; Rats; Reward; Self Stimulation; Substance-Related Disorders | 1984 |
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
Topics: Alcoholism; Bromocriptine; Dopamine Agonists; Female; Fluoxetine; Humans; Male; Models, Psychological; Naltrexone; Narcotic Antagonists; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 1996 |
Opioid peptides and the control of human ingestive behaviour.
Topics: Alcoholism; Appetite Regulation; Drinking Behavior; Feeding Behavior; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Substance-Related Disorders; Time Factors; Water Intoxication | 2002 |
Contingency management: utility in the treatment of drug abuse disorders.
Topics: Behavior Therapy; Buprenorphine; Cocaine-Related Disorders; Humans; Motivation; Naltrexone; Narcotic Antagonists; Patient Compliance; Receptors, Opioid, mu; Reinforcement, Psychology; Reward; Substance Abuse Detection; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome | 2008 |
[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
Topics: Alcoholism; Animals; beta-Endorphin; Dopamine; GABA Antagonists; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reinforcement, Psychology; Reward | 2008 |
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
Topics: Animals; Behavior, Addictive; Humans; Motivation; Naltrexone; Neurotransmitter Agents; Nicotine; Opioid Peptides; Receptors, Nicotinic; Reinforcement, Psychology; Reward; Smoking Cessation; Tobacco Use Disorder | 2010 |
Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.
Topics: Animals; Central Nervous System; Humans; Naltrexone; Narcotic Antagonists; Neuroglia; Neurons; Reward; Substance-Related Disorders; Toll-Like Receptor 4; Xenobiotics | 2015 |
Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction.
Topics: Alcoholism; Analgesics, Opioid; Animals; Genotype; Humans; Models, Animal; Naltrexone; Reward | 2016 |
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Brain; Buprenorphine; Disease Models, Animal; Endocannabinoids; Glutamic Acid; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Orexins; Reward; Secondary Prevention; Signal Transduction; Treatment Outcome | 2020 |
28 trial(s) available for naltrexone and s,n,n'-tripropylthiocarbamate
Article | Year |
---|---|
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
Topics: Adult; Behavior Therapy; Combined Modality Therapy; Family Therapy; Female; Humans; Interpersonal Relations; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Reward; Substance Abuse Detection; Treatment Outcome; Treatment Refusal | 2001 |
Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls.
Topics: Adult; Alcoholism; Bias; Brain; Causality; Central Nervous System Depressants; Choice Behavior; Decision Making; Double-Blind Method; Ethanol; Female; Humans; Impulsive Behavior; Male; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Opioid Peptides; Personality; Psychomotor Performance; Reward; Treatment Outcome | 2007 |
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Breath Tests; Double-Blind Method; Emotions; Ethanol; Female; Genetic Variation; Genotype; Humans; Male; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Placebos; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Opioid, mu; Reward | 2007 |
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans.
Topics: Adult; Amygdala; Brain; Brain Mapping; Corpus Striatum; Dose-Response Relationship, Drug; Fentanyl; Food; Humans; Indans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Radioligand Assay; Radionuclide Imaging; Reward; Triazoles | 2011 |
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
Topics: Adult; Analysis of Variance; Cues; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Reward; Substance Abuse, Intravenous; Sucrose; Taste Perception | 2012 |
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult | 2012 |
Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems.
Topics: Adult; Arm; Attitude to Health; Cannabinoid Receptor Antagonists; Culture; Double-Blind Method; Female; Humans; Ischemia; Male; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Persuasive Communication; Physical Endurance; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reward; Rimonabant; Suggestion; Time Factors; Young Adult | 2013 |
Rewards of beauty: the opioid system mediates social motivation in humans.
Topics: Analgesics, Opioid; Beauty; Cross-Over Studies; Double-Blind Method; Face; Humans; Male; Morphine; Motivation; Naltrexone; Narcotic Antagonists; Photic Stimulation; Receptors, Opioid, mu; Reward | 2014 |
Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.
Topics: Adult; Affect; Brain Mapping; Cerebrum; Double-Blind Method; Female; Food; Humans; Magnetic Resonance Imaging; Naltrexone; Narcotic Antagonists; Obesity; Reward; Taste; Young Adult | 2014 |
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs | 2015 |
Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.
Topics: Adult; Craving; Eating; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Obesity; Pilot Projects; Reward; Treatment Outcome; Young Adult | 2015 |
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
Topics: Adult; Behavior, Addictive; Biomedical Research; Brain; Cocaine; Cross-Over Studies; Drug Discovery; Ethanol; Female; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Neurokinin-1 Receptor Antagonists; Pharmaceutical Preparations; Receptors, Dopamine D3; Receptors, Neurokinin-1; Reward; Secondary Prevention; Substance-Related Disorders | 2015 |
Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
Topics: Amisulpride; Cues; Delay Discounting; Dopamine Antagonists; Double-Blind Method; Female; Healthy Volunteers; Humans; Impulsive Behavior; Male; Naltrexone; Narcotic Antagonists; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; Reward; Sulpiride; Young Adult | 2016 |
Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Reproducibility of Results; Reward; Taurine; Treatment Outcome | 2017 |
Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.
Topics: Adult; Alcoholism; Corpus Striatum; Delay Discounting; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Reward; Substance-Related Disorders; United Kingdom | 2017 |
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study.
Topics: Administration, Intravenous; Adult; Alcoholism; Anticipation, Psychological; Corpus Striatum; Double-Blind Method; Drug Synergism; Ethanol; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Reward | 2017 |
Opioid Modulation of Value-Based Decision-Making in Healthy Humans.
Topics: Adult; Analgesics, Opioid; Computer Simulation; Cross-Over Studies; Decision Making; Double-Blind Method; Humans; Models, Neurological; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Reaction Time; Receptors, Opioid, mu; Reward; Young Adult | 2017 |
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
Topics: Alcoholism; Brain; Brain Mapping; Cues; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pharmacogenomic Variants; Prognosis; Receptors, Opioid, mu; Reward; Severity of Illness Index; Single-Blind Method; Smoking; Visual Perception | 2017 |
Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.
Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Phenotype; Precision Medicine; Reward; Treatment Outcome | 2018 |
Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial.
Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Emotions; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Reward; Touch; Touch Perception; Young Adult | 2019 |
Opioids and social bonding: Effect of naltrexone on feelings of social connection and ventral striatum activity to close others.
Topics: Adolescent; Adult; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Reward; Social Behavior; Ventral Striatum; Young Adult | 2020 |
Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Precision Medicine; Reward; Treatment Outcome | 2019 |
Opioid receptor blockade inhibits self-disclosure during a closeness-building social interaction.
Topics: Adolescent; Adult; Double-Blind Method; Emotions; Female; Humans; Interpersonal Relations; Male; Motivation; Naltrexone; Narcotic Antagonists; Personality; Receptors, Opioid; Reward; Self Disclosure; Social Interaction; Young Adult | 2020 |
Reward drinking and naltrexone treatment response among young adult heavy drinkers.
Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Blood Alcohol Content; Female; Humans; Male; Naltrexone; Reward; Young Adult | 2021 |
Opioid antagonism modulates wanting-related frontostriatal connectivity.
Topics: Adult; Amisulpride; Corpus Striatum; Dopamine Antagonists; Dorsolateral Prefrontal Cortex; Double-Blind Method; Female; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Motivation; Naltrexone; Narcotic Antagonists; Reward | 2021 |
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine's effects.
Topics: Adult; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Methamphetamine; Naltrexone; Punishment; Reward | 2022 |
The role of opioid transmission in music-induced pleasure.
Topics: Analgesics, Opioid; Music; Naltrexone; Oxycodone; Pleasure; Reward | 2023 |
Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users.
Topics: Alcoholism; Analgesics, Opioid; Humans; Magnetic Resonance Imaging; Naltrexone; Narcotic Antagonists; Pilot Projects; Receptors, Opioid; Reward | 2023 |
85 other study(ies) available for naltrexone and s,n,n'-tripropylthiocarbamate
Article | Year |
---|---|
Opioids and feeding reward.
Topics: Animals; Appetite Regulation; Endorphins; Feeding Behavior; Naloxone; Naltrexone; Rats; Reward | 1991 |
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
Topics: Animals; Benzomorphans; Caudate Nucleus; Dopamine; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Septal Nuclei | 1988 |
Role of pituitary and related neuropeptides in alcoholism and pharmacodependence.
Topics: Adrenocorticotropic Hormone; Alcoholism; Animals; Arginine Vasopressin; beta-Endorphin; Brain; Endorphins; Haplorhini; Heroin Dependence; Humans; Melanocyte-Stimulating Hormones; Naltrexone; Neurotransmitter Agents; Peptides; Pituitary Gland; Rats; Reinforcement, Psychology; Reward; Substance-Related Disorders | 1986 |
An analysis of the paradoxical effect of morphine on runway speed and food consumption.
Topics: Animals; Avoidance Learning; Feeding Behavior; Food Deprivation; Male; Morphine; Motivation; Naltrexone; Nervous System; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Reward; Taste; Tegmentum Mesencephali | 1986 |
Evidence of a supraspinal opioid analgesic mechanism engaged by lateral hypothalamic electrical stimulation.
Topics: Animals; Brain Mapping; Electric Stimulation; Endorphins; Hypothalamic Area, Lateral; Male; Naltrexone; Pain; Rats; Rats, Inbred Strains; Reward; Sensory Thresholds | 1985 |
The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.
Topics: Animals; Association Learning; Cocaine; Conditioning, Operant; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Sensitivity and Specificity | 1995 |
Norbinaltorphimine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation.
Topics: Animals; Electric Stimulation; Feeding Behavior; Hypothalamic Area, Lateral; Injections, Intraventricular; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation | 1993 |
Streptozotocin-induced diabetes produces a naltrexone-reversible lowering of self-stimulation threshold.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Streptozocin | 1994 |
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward | 1993 |
The role of multiple opioid receptors in the potentiation of reward by food restriction.
Topics: Animals; Behavior, Animal; Brain; Conditioning, Operant; Dose-Response Relationship, Drug; Food Deprivation; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Self Stimulation | 1994 |
Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine.
Topics: Animals; Benzazepines; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Self Administration; Time Factors | 1995 |
kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzeneacetamides; Cocaine; Conditioning, Psychological; Dopamine; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward | 1996 |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation.
Topics: Animals; Brain; Electric Stimulation; Male; Medial Forebrain Bundle; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Self Stimulation; Serotonin Agents | 1996 |
Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
Topics: Analgesics; Animals; Benzylidene Compounds; Dopamine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Limbic System; Male; Mice; Morphine; Naltrexone; Quinolines; Receptors, Opioid, delta; Reward | 1996 |
Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
Topics: Animals; Body Weight; Calcium Channel Blockers; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Drinking; Drug Interactions; Ethanol; Isradipine; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward | 1998 |
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone.
Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid | 1998 |
Regulation of cocaine reward by CREB.
Topics: Animals; Cocaine; Conditioning, Psychological; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Dynorphins; Gene Expression; Gene Expression Regulation; Gene Transfer Techniques; Genetic Vectors; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Point Mutation; Rats; Receptors, Opioid, kappa; Reward; RNA, Messenger; Simplexvirus | 1998 |
Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain.
Topics: Animals; Chronic Disease; Conditioning, Psychological; Formaldehyde; Hindlimb; Inflammation; Male; Morphine; Naltrexone; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Reward; Time Factors | 1999 |
Naltrexone effects on ethanol reward and discrimination in C57BL/6 mice.
Topics: Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Ethanol; Food Deprivation; Generalization, Response; Habituation, Psychophysiologic; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Reinforcement Schedule; Reward | 1999 |
Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.
Topics: Alcohol Drinking; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Classical; Conditioning, Operant; Drinking Behavior; Ethanol; Macaca mulatta; Male; Naltrexone; Reward; Sodium Chloride; Taste | 1999 |
Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.
Topics: Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Reinforcement, Psychology; Reward; Serotonin Antagonists; Tropanes | 2000 |
Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone.
Topics: Animals; Ethanol; Food Deprivation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Reinforcement, Psychology; Reward; Saccharin; Self Administration; Solutions; Sucrose; Water Deprivation | 2000 |
The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
Topics: Animals; Dose-Response Relationship, Drug; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotics; Receptors, Opioid, kappa; Reward; Spiro Compounds | 2001 |
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.
Topics: Analgesia; Animals; Behavior, Animal; Cocaine; Drug Synergism; Enkephalins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naltrexone; Narcotic Antagonists; Pain Threshold; Protein Precursors; Reaction Time; Receptors, Opioid, kappa; Reward; Spatial Behavior; Stress, Physiological; Swimming | 2003 |
Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
Topics: Animals; Behavior, Animal; Benzeneacetamides; Brain; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Electric Stimulation; Electrodes, Implanted; Injections, Intraperitoneal; Ligands; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation; Time Factors | 2004 |
The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Avoidance Learning; Brain Chemistry; Chromatography, High Pressure Liquid; Dialysis; Dopamine; Homovanillic Acid; Mice; Mice, Inbred Strains; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Receptors, Opioid, mu; Reward; Species Specificity; Time Factors | 2004 |
Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
Topics: Animals; Brain Chemistry; Conditioning, Operant; Dopamine; Dynorphins; Edema; Foot; Formaldehyde; Inflammation; Limbic System; Male; Microdialysis; Microinjections; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward | 2005 |
Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward.
Topics: Animals; Behavior, Addictive; Central Nervous System Stimulants; Conditioning, Operant; Male; Methamphetamine; Naltrexone; Narcotic Antagonists; Rats; Reward; Self Administration | 2004 |
Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
Topics: Animals; Avoidance Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Morphine Dependence; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Orientation; Oxycodone; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome | 2005 |
Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
Topics: Animals; Avoidance Learning; Conditioning, Operant; Cues; Electroshock; Extinction, Psychological; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Oxycodone; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement Schedule; Reward; Self Administration | 2005 |
Health for life. Addiction: how to break the chain.
Topics: Behavior, Addictive; Brain; Dopamine Agonists; Humans; Naltrexone; Narcotic Antagonists; Reinforcement, Psychology; Reward; Substance-Related Disorders; United States | 2005 |
Pharmacological manipulations of dopamine and opioids have differential effects on sexually motivated song in male European starlings.
Topics: Analgesics, Opioid; Animals; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Implants; Female; Fentanyl; Male; Motivation; Naltrexone; Narcotic Antagonists; Orchiectomy; Piperazines; Receptors, Dopamine D1; Receptors, Opioid; Reward; Sexual Behavior, Animal; Starlings; Testosterone; Vocalization, Animal | 2006 |
Noradrenaline is necessary for the hedonic properties of addictive drugs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Appetitive Behavior; Benzazepines; Biphenyl Compounds; Bupropion; Carbidopa; Cocaine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Droxidopa; Female; Genotype; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reward; Substance-Related Disorders | 2006 |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Psychological; Diterpenes; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Hallucinogens; Models, Animal; Motor Activity; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Reinforcement, Psychology; Reproducibility of Results; Reward; Rimonabant; Swimming; Time Factors; Zebrafish | 2007 |
Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats.
Topics: Animals; Behavior, Animal; Cocaine-Related Disorders; Cues; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Sucrose | 2008 |
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Choice Behavior; Dose-Response Relationship, Drug; Family; Female; Genetic Predisposition to Disease; Humans; Male; Naltrexone; Narcotic Antagonists; Reward; Sex Factors; Treatment Outcome | 2007 |
Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding.
Topics: Analgesics, Opioid; Animals; Bulimia Nervosa; Diet; Dietary Fats; Dose-Response Relationship, Drug; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Preferences; Homeostasis; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reward; Sucrose | 2007 |
Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.
Topics: Animals; Brain; Drinking; Female; Food Preferences; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Rats; Rats, Long-Evans; Reward; Sex Characteristics; Solutions; Stress, Psychological; Substance-Related Disorders; Sucrose | 2007 |
CREB1 haplotypes and the relative reinforcing value of nicotine.
Topics: Association Learning; Case-Control Studies; Choice Behavior; Cyclic AMP Response Element-Binding Protein; Double-Blind Method; Haplotypes; Humans; Linkage Disequilibrium; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Regression Analysis; Reward; Smoking; Tobacco Use Disorder | 2007 |
Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
Topics: Analysis of Variance; Animals; Antioxidants; Behavior, Animal; Cannabinoid Receptor Modulators; Conditioning, Operant; Diterpenes; Diterpenes, Clerodane; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Endocannabinoids; Male; Microdialysis; Motor Activity; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reward; Rimonabant; Self Administration | 2008 |
Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.
Topics: Animals; Conditioning, Psychological; Drug Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Reward; Spatial Behavior | 2009 |
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
Topics: Amphetamine; Animals; Appetitive Behavior; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Abuse, Intravenous | 2009 |
Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
Topics: Administration, Oral; Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Drug Administration Routes; Drug Administration Schedule; Gas Chromatography-Mass Spectrometry; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward | 2009 |
Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity.
Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Psychological; Cues; Enkephalins; Gene Expression Regulation; Genotype; In Situ Hybridization; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine Dependence; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Phenotype; Protein Precursors; Receptors, Opioid, kappa; Reward; RNA, Messenger; Species Specificity | 2010 |
Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Conditioning, Psychological; Enkephalins; Ethanol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Protein Precursors; Receptors, Opioid, kappa; Reward; Self Administration; Signal Transduction; Stress, Physiological | 2010 |
Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analysis of Variance; Anesthetics, Local; Animals; Association Learning; Behavior, Animal; Cocaine; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Dynorphins; Exploratory Behavior; Male; Mental Recall; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Reward; Stress, Psychological; Swimming | 2010 |
Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethanol; Male; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pyridines; Rats; Receptors, Nicotinic; Reward; Saccharin; Self Administration | 2010 |
Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
Topics: Animals; Appetitive Behavior; Male; Microinjections; Motivation; Naltrexone; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reinforcement, Psychology; Reward; Sucrose | 2010 |
Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats.
Topics: Animals; Behavior, Addictive; Behavioral Research; Cocaine; Conditioning, Psychological; Infusions, Intraventricular; Maze Learning; Motor Activity; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, delta; Reward | 2010 |
Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward.
Topics: Amygdala; Animals; Conditioning, Operant; Drive; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Food; Guanidines; Male; Microinjections; Morphinans; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Rats; Rats, Long-Evans; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Somatostatin; Sucrose | 2011 |
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
Topics: Animals; Cocaine; Cyclic AMP Response Element-Binding Protein; Diterpenes, Clerodane; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Male; Naltrexone; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation; Signal Transduction; Time Factors | 2011 |
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.
Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Reinforcement, Psychology; Reward; Substance P | 2012 |
Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward.
Topics: Animal Feed; Animals; Feeding Behavior; Ghrelin; Homeostasis; Infusions, Intraventricular; Male; Models, Biological; Motivation; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, Opioid, mu; Reward; Sucrose; Ventral Tegmental Area | 2012 |
μ- and δ-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice.
Topics: Animals; Choice Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Nucleus Accumbens; Peptide Fragments; Random Allocation; Rats; Rats, Long-Evans; Receptors, Opioid, delta; Receptors, Opioid, mu; Reward; Somatostatin | 2012 |
The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.
Topics: Animals; Behavior, Animal; beta-Endorphin; Cocaine; Conditioning, Operant; Male; Mice; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reward | 2012 |
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens.
Topics: Alcohol Drinking; Animals; Behavioral Symptoms; Cues; Disease Models, Animal; Dopamine; Drug Discovery; Ethanol; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Rats; Reward; Secondary Prevention; Substance Withdrawal Syndrome | 2012 |
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Topics: Animals; Avoidance Learning; Brain; Cocaine; Corpus Striatum; Dopamine; Dynorphins; G-Protein-Coupled Receptor Kinase 3; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microinjections; Naltrexone; Narcotic Antagonists; Nicotine; Nucleus Accumbens; p38 Mitogen-Activated Protein Kinases; Raphe Nuclei; Receptors, Opioid, kappa; Reward; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stress, Psychological; Substance Withdrawal Syndrome; Synaptosomes | 2012 |
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Conditioning, Psychological; Cues; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward | 2014 |
Rewarding effects of ethanol combined with low doses of morphine through dopamine D1 receptors.
Topics: Analgesics, Opioid; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Ethanol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reward | 2013 |
Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Ethanol; Male; Motivation; Naltrexone; Rats; Rats, Wistar; Reinforcement, Psychology; Reward; Saccharin; Self Administration; Sucrose; Water Deprivation | 2014 |
Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.
Topics: Analgesics; Animals; Conditioning, Psychological; Genetic Vectors; HEK293 Cells; Humans; Lentivirus; Male; Mice, Inbred C57BL; Morphine; Mutation; Naltrexone; Narcotic Antagonists; Neuralgia; Receptors, Opioid, mu; Reward; Spinal Cord; Spinal Nerves; Substance Withdrawal Syndrome; Transfection | 2015 |
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.
Topics: Analgesics, Opioid; Animals; CHO Cells; Compulsive Behavior; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Indans; Ligands; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Protein Binding; Receptors, Opioid, mu; Reward; Treatment Outcome; Triazoles | 2015 |
Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Isomerism; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Pain; Pentazocine; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Reward | 2015 |
Sexual performance and precontact 50-kHz ultrasonic vocalizations in WAG/Rij rats: effects of opioid receptor treatment.
Topics: Animals; Disease Models, Animal; Epilepsy, Absence; Female; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid; Reward; Sexual Behavior, Animal; Vocalization, Animal | 2014 |
A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.
Topics: Alcohol Drinking; Animals; Conditioning, Operant; Electric Stimulation; Ethanol; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naltrexone; Receptors, Opioid, mu; Reward; Self Administration | 2015 |
Complexities of the mu opioid receptor.
Topics: Alcohol Drinking; Animals; Humans; Male; Naltrexone; Receptors, Opioid, mu; Reward | 2015 |
Pharmacotherapy: Quest for the quitting pill.
Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins | 2015 |
Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.
Topics: Analgesics, Opioid; Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Psychological; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Morphinans; Naltrexone; Nociception; Nuclear Receptor Subfamily 1, Group F, Member 1; Random Allocation; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Spatial Behavior | 2015 |
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats.
Topics: Animals; Cannabidiol; Cocaine; Conditioning, Classical; Cues; Disease Models, Animal; Male; Memory; Mental Recall; Morphine; Naltrexone; Rats; Rats, Wistar; Reward | 2017 |
The µ-opioid system promotes visual attention to faces and eyes.
Topics: Adult; Analgesics, Opioid; Attention; Cues; Eye Movements; Face; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reward; Social Behavior; Visual Perception; Young Adult | 2016 |
Choice between delayed food and immediate oxycodone in rats.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Choice Behavior; Delay Discounting; Disease Models, Animal; Eating; Feeding Behavior; Humans; Male; Naltrexone; Oxycodone; Rats; Reward; Time Factors | 2016 |
Evaluation of effect of minocycline on rewarding potential and alcohol relapse in place preference model in mice.
Topics: Alcohol Drinking; Alcoholism; Animals; Conditioning, Classical; Conditioning, Operant; Disease Models, Animal; Ethanol; Extinction, Psychological; Male; Mice; Minocycline; Naltrexone; Reward; Secondary Prevention | 2017 |
Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
Topics: Alcohol Drinking; Alleles; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Quinine; Receptors, Opioid, mu; Reflex; Reward; Self Administration; Self Stimulation; Sex Characteristics | 2018 |
The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.
Topics: Animals; Choice Behavior; Circadian Rhythm; Drug-Seeking Behavior; Ethanol; Hypothalamus; Immunity, Innate; Male; Mice, Inbred BALB C; Naltrexone; Nucleus Accumbens; Photoperiod; Reward; Toll-Like Receptor 4 | 2018 |
Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Choice Behavior; Conditioning, Operant; Delay Discounting; Dose-Response Relationship, Drug; Feeding Behavior; Individuality; Injections, Intravenous; Male; Naltrexone; Oxycodone; Piperidines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Remifentanil; Reward; Self Administration; Time Factors | 2017 |
Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.
Topics: Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Drug Interactions; Dynorphins; Excitatory Postsynaptic Potentials; Extinction, Psychological; Male; Microinjections; Miniature Postsynaptic Potentials; Naltrexone; Orexins; Paraventricular Hypothalamic Nucleus; Rats; Reward; Self Administration | 2018 |
Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.
Topics: Adult; Brain; Delayed-Action Preparations; Facial Recognition; Female; Humans; Magnetic Resonance Imaging; Maternal Behavior; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Reward | 2018 |
Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats.
Topics: Animals; Anti-Obesity Agents; Brain; Bupropion; Drug Combinations; Feeding Behavior; Gene Expression Regulation; High Fructose Corn Syrup; Male; Motor Activity; Naltrexone; Random Allocation; Rats, Sprague-Dawley; Reward; RNA, Messenger; Self Administration | 2018 |
Ethanol Exposure History and Alcoholic Reward Differentially Alter Dopamine Release in the Nucleus Accumbens to a Reward-Predictive Cue.
Topics: Animals; Conditioning, Classical; Cues; Dopamine; Electrochemical Techniques; Ethanol; Male; Naltrexone; Nucleus Accumbens; Rats; Reward | 2018 |
Antagonism of μ-opioid receptors reduces sensation seeking-like behavior in mice.
Topics: Animals; Appetitive Behavior; Brain; Conditioning, Operant; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice, Inbred C57BL; Morphinans; Motivation; Motor Activity; Naltrexone; Narcotic Antagonists; Random Allocation; Receptors, Opioid; Receptors, Opioid, mu; Reward | 2019 |
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Feeding Behavior; Food Deprivation; Hunger; Male; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Reward; Satiation; Time Perception | 2020 |
Dopaminergic and opioidergic regulation during anticipation and consumption of social and nonsocial rewards.
Topics: Adult; Amisulpride; Dopamine Antagonists; Emotions; Female; Food; Humans; Male; Naltrexone; Narcotic Antagonists; Pleasure; Reward; Young Adult | 2020 |
The role of opioidergic system in modulating cost/benefit decision-making in alcohol-preferring AA rats and Wistar rats.
Topics: Alcohol Drinking; Analgesics, Opioid; Animals; Behavior, Animal; Cost-Benefit Analysis; Decision Making; Gambling; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Sucrose | 2021 |
Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Psychometrics; Reward | 2022 |
Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.
Topics: Adult; Cholinergic Agents; Decision Making; Dopamine; Humans; Motivation; Naltrexone; Nicotine; Pilot Projects; Reward | 2022 |